Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M361Revenue (TTM) $M7.0Net Margin (%)-622.7Altman Z-Score-0.4
Enterprise Value $M236EPS (TTM) $-1.0Operating Margin %-631.1Piotroski F-Score4
P/E(ttm)--Beneish M-Score1.6Pre-tax Margin (%)-622.7Higher ROA y-yN
Price/Book6.610-y EBITDA Growth Rate %--Quick Ratio4.7Cash flow > EarningsY
Price/Sales49.85-y EBITDA Growth Rate %76.8Current Ratio4.7Lower Leverage y-yY
Price/Free Cash Flow9.0y-y EBITDA Growth Rate %--ROA % (ttm)-43.1Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-66.9Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M47.8ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with CCXI

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

CCXI is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!

CCXI: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Cappel Markus J.Chief Bus. Officer & Treasurer 2017-01-03Sell26,821$7.510.67view
Bekker PetrusChief Medical Officer 2016-12-16Sell8,712$8.74-13.5view
Bekker PetrusChief Medical Officer 2016-12-05Sell30,000$8.5-11.06view
Bekker PetrusChief Medical Officer 2016-11-22Sell1,250$8.3-8.92view
Bekker PetrusChief Medical Officer 2016-11-11Sell33,332$8-5.5view
LUCAS ROGER CDirector 2016-11-01Sell4,000$6.123.93view
LUCAS ROGER CDirector 2016-09-01Sell4,000$5.0749.11view
Tyree James LDirector 2016-05-23Sell5,544$4.3972.21view
Edwards Thomas A.Director 2016-05-17Buy50,000$4.0586.67view
Edwards Thomas A.Director 2016-05-16Buy25,000$4.0586.67view

Quarterly/Annual Reports about CCXI:

News about CCXI:

Articles On GuruFocus.com
Immune Design Insider Buys Shares Oct 03 2016 
Three Attractively Priced Small Cap Biotech Stocks Nov 05 2014 

More From Other Websites
3:34 pm ChemoCentryx presents from a continuing open-label, single-arm Phase Ib clinical trial of... Jan 20 2017
ChemoCentryx Announces Presentation of Data from Ongoing Phase Ib Clinical Trial of CCR2 Inhibitor... Jan 20 2017
ChemoCentryx, Inc. (Nasdaq: CCXI) to Ring The Nasdaq Stock Market Closing Bell Remotely from the... Jan 20 2017
ChemoCentryx, Inc. breached its 50 day moving average in a Bullish Manner : CCXI-US : January 19,... Jan 19 2017
ChemoCentryx Provides Corporate Update Including Development Strategy for Lead Programs in Rare... Jan 09 2017
ChemoCentryx to Present at the 35th Annual J.P. Morgan Healthcare Conference Jan 04 2017
ChemoCentryx, Inc. – Value Analysis (NASDAQ:CCXI) : January 3, 2017 Jan 03 2017
ChemoCentryx, Inc. breached its 50 day moving average in a Bearish Manner : CCXI-US : January 2,... Jan 02 2017
Vifor Pharma and ChemoCentryx announce expansion of Kidney Health Alliance to include CCX140 to... Dec 23 2016
ChemoCentryx Expands Partnership With Vifor Pharma, Licenses CCX140 For Renal Diseases Dec 22 2016
CHEMOCENTRYX, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement Dec 22 2016
Vifor Pharma and ChemoCentryx Announce Expansion of Kidney Health Alliance to Include CCX140 to... Dec 22 2016
Is ChemoCentryx Inc (CCXI) A Stock Worth Buying? Dec 16 2016
Everyday Health Inc (EVDY), ANSYS, Inc. (ANSS), More: Why You Should Pay Attention To These Stocks Nov 16 2016
CHEMOCENTRYX, INC. Financials Nov 16 2016
CHEMOCENTRYX, INC. Files SEC form 10-Q, Quarterly Report Nov 08 2016
Edited Transcript of CCXI earnings conference call or presentation 7-Nov-16 10:00pm GMT Nov 08 2016
CHEMOCENTRYX, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Nov 07 2016
ChemoCentryx Reports Third Quarter 2016 Financial Results and Provides Corporate Update Nov 07 2016
ChemoCentryx to Hold Third Quarter 2016 Financial Results Conference Call on Monday, November 7,... Nov 07 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)